Literature DB >> 11164691

The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients.

J S Cacciola1, A I Alterman, M J Rutherford, J R McKay, F D Mulvaney.   

Abstract

The authors examined the relationship of comorbid non-substance use psychiatric disorders to preadmission problem status and treatment outcomes in 278 methadone maintenance patients. Recent admissions were assigned DSM-III-R Axis I and II diagnoses according to structured diagnostic interviews. The Addiction Severity Index was administered at admission to assess past and current substance use and psychosocial problems and again 7 months later. Treatment retention and month 7 drug urinalysis results were also obtained. Across substance use and psychosocial domains, participants showed significant and comparable levels of improvement regardless of comorbidity. Comorbid participants received more concurrent psychiatric treatment which may have accounted for the lack of differential improvement among groups. Nevertheless, psychiatric comorbidity was associated with poorer psychosocial and medical status at admission and follow-up and participants with the combination of Axis I and II comorbidity had the most severe problems. Admission and month 7 substance use were, for the most part, not related to psychiatric comorbidity, although there was a trend indicating more treatment attrition for participants with personality disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164691     DOI: 10.1016/s0376-8716(00)00148-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  47 in total

1.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

2.  Validation of the Orbach & Mikulincer Mental Pain Scale (OMMP) on a drug addicted population.

Authors:  Rui Guimarães; Manuela Fleming; Margarida Fonseca Cardoso
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-31       Impact factor: 4.328

3.  The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.

Authors:  Elizabeth C Saunders; Mark P McGovern; Chantal Lambert-Harris; Andrea Meier; Bethany McLeman; Haiyi Xie
Journal:  Am J Addict       Date:  2015-09-21

4.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

5.  Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.

Authors:  Margaret L Griffin; Dorian R Dodd; Jennifer S Potter; Lindsay S Rice; William Dickinson; Steven Sparenborg; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2013-11-12       Impact factor: 3.829

6.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

7.  Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.

Authors:  Declan T Barry; Christopher J Cutter; Mark Beitel; Robert D Kerns; Christopher Liong; Richard S Schottenfeld
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

8.  Exercise for methamphetamine dependence: rationale, design, and methodology.

Authors:  Larissa J Mooney; Christopher Cooper; Edythe D London; Joy Chudzynski; Brett Dolezal; Daniel Dickerson; Mary-Lynn Brecht; Jose Peñate; Richard A Rawson
Journal:  Contemp Clin Trials       Date:  2013-11-28       Impact factor: 2.226

9.  Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study.

Authors:  Mònica Astals; Laura Díaz; Antònia Domingo-Salvany; Rocío Martín-Santos; Antoni Bulbena; Marta Torrens
Journal:  Int J Environ Res Public Health       Date:  2009-11-12       Impact factor: 3.390

10.  Dialectical behavior therapy for substance abusers.

Authors:  Linda A Dimeff; Marsha M Linehan
Journal:  Addict Sci Clin Pract       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.